News
Summary of the article
Food allergies are increasingly common, with millions affected worldwide and a significant number at risk of severe reactions like anaphylaxis. While avoidance remains the primary strategy, it's difficult to guarantee safety, and even mild exposure can have serious consequences. Current treatments focus on immunotherapy, where patients are slowly exposed to allergens to train the immune system, but this is time-consuming, can cause allergic reactions, and isn’t a permanent cure. Promising advancements include boiled peanut extracts and nanoparticle-based therapies that target specific allergy-causing proteins. Drugs like omalizumab and dupilumab, which dampen immune responses, have shown encouraging results, especially when combined with immunotherapy to improve safety and effectiveness. Inspired by the success of insect venom immunotherapy, researchers are exploring how to replicate its long-lasting protection, potentially through targeted manipulation of molecules like interleukin-6. These efforts offer hope that, with the right combination of therapies, a true cure for food allergies may eventually be possible.
Insights shared by Cezmi Akdis*
To truly cure food allergies, we must understand why they have increased so dramatically since the 1990s. According to research, lifestyle changes, including increased exposure to ultra-processed foods, dishwashers and microplastics, may be damaging the epithelial barrier that protects our bodies. This disruption can lead to inflammation, imbalanced gut microbes, and a hypersensitive immune system prone to allergic reactions. Lab studies show common chemicals in dishwashing agents can harm gut cells, potentially triggering food allergies. While immunotherapy and medications are valuable, lasting solutions require addressing these environmental and lifestyle factors that may be setting our immune systems up to fail.
*Director of the Swiss Institute of Allergy and Asthma Research and professor at the University of Zurich in Davos, Switzerland
Summary of the article
A recent study shows that oral immunotherapy can reduce allergic reactions in adults with peanut allergies, a method already approved for children. Peanut allergies occur when the immune system overreacts to peanut proteins, producing excess IgE antibodies that can trigger symptoms likes welling or, in severe cases, anaphylaxis. Researchers gradually increased daily peanut protein doses for adult participants until most could tolerate the equivalent of four large peanuts. Out of 21 participants, 15 completed the trial, and nearly all could eat five peanuts without reacting. Blood tests showed an increase in IgG antibodies, which help neutralize the allergic effects of IgE. Experts find the results promising, suggesting this could ease daily anxiety for adults with peanut allergies. However, larger studies are needed to confirm the findings and determine how long the effects last.
Cezmi Akdis, from the Swiss Institute of Allergy and Asthma Research, commented on a clinical trial testing oral immunotherapy for peanut allergy. He described the dropout rate—due to allergic reactions and unrelated reasons—as acceptable for this kind of treatment. He called the results "very promising", noting that most participants could safely consume the equivalent of five peanut safter therapy. Akdis explained that the treatment worked by boosting IgG antibodies, which counteract allergic IgE responses. However, he emphasized that larger trials are needed, and long-term tolerance may require regular peanut consumption, similar to taking a daily pill.